NEWARK, DE / ACCESSWIRE / May 31, 2023 / The global Neonatal Thermoregulation Market is anticipated to expand significantly and reach an estimated value of US$ 1,151.6 million by 2033, according to Future Market Insights (FMI).
In 2023, the global neonatal thermoregulation market is expected to be worth US$ 661.8 million. The market is expected to register a 5.7% CAGR from 2023 to 2033.
For the last decade, the increasing importance of neonatal treatment has fueled the sales of neonatal thermoregulation equipment manufacturers all over the world, while an increase in popularity from the hospital sector is further adapting to it. Despite briefly declining during the deadly COVID-19 pandemic in 2020, industry players are regaining speed with the consistent recovery in key end-use industries.
Get your PDF Sample report with Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5881
- In 2023, the global market is expected to be worth US$ 661.8 million.
- Over the next few decades, the Indian market is expected to grow at a CAGR of 5.3%.
- Over the next few decades, Germany's market is projected to grow at a CAGR of 3.7%.
- Over the next few decades, China's market is predicted to grow at a CAGR of 6.3%.
- In 2022, the United States held an 18% revenue share in the market for neonatal thermoregulation.
"The need for proper thermoregulation to guarantee newborns' health and well-being is gaining traction in the hospital sector. Furthermore, developments in the neonatal and pediatric intensive care sectors are assisting in the growth of participants," - says an analyst at FMI.
There is an extended need for R&D, which is still a major approach among market players. Another common strategy for gaining an edge over rivals is the collaborative strategy. Some of the latest developments are
- GE Healthcare created a Giraffe Incubator Carestation in April 2022. The Giraffe Carestation is a cutting-edge neonatal facility aimed at encouraging natural and calm healing. It strengthens the family's bond with the infant, permitting them to be present at each phase.
- Natus Medical Incorporated, an acknowledged innovator of medical device products for the detection, diagnosis, and treatment of conditions impacting the brain, neural circuits, and eight sensory areas, disclosed in April 2022 that it had entered into an official agreement to be purchased by a Natus Medical Incorporated subsidiary. ArchiMed is a healthcare-focused startup with a $1.2 billion estimation.
Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-5881
More Valuable Insights:
Future Market Insights, in its new offering, presents an unbiased analysis of the global neonatal thermoregulation market presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights by Product Type (Warmer, Neonatal Incubators, Neonatal Cooling Systems), Modality (Open, Close), End User & Region.
Some of the Major Players are:
- GE Healthcare
- Natus Medical Incorporated
- Inspiration Healthcare Group Plc.
- Koninklijke Philips N.V.
- Dragerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare
- International Biomedical, Ltd.
- Atom Medical Corporation
- Fanem Ltda
- Novos Medical Systems
- Pluss Advanced Technologies Pvt. Ltd.
- Weyer GmbH
For more Report Customization, connect with us at https://www.futuremarketinsights.com/customization-available/rep-gb-5881
Key Segments Profiled:
By Product Type:
- Radiant Warmer
- Wall Mount Warmer
- Neonatal Incubators
- Intensive Care Incubator
- Hybrid Incubator
- Selective Close Care Incubators
- Transport Incubator
- Intensive Care Incubator
- Neonatal Cooling Systems
By End User:
- Paediatric and Neonatal
- Intensive Care Units
- North America
- Latin America
- Middle East and Africa
- East Asia
- South Asia
Get an instant 20% discount on this report - Buy Now!
Table of Content (ToC):
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.2. Scenario Forecast
View the Complete ToC of this Report with figures here @ https://www.futuremarketinsights.com/toc/rep-gb-5881
About the Healthcare Division at Future Market Insights (FMI):
The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with the objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Explore FMI's related ongoing Coverage in Healthcare Market Domain:
Dengue Vaccines Market Size: The dengue vaccines market will register positive growth with the overall valuation forecast to reach US$ 474.8 million in 2023. The demand for dengue vaccines is projected to surge with a projected CAGR of 12.9% by sales in volume (units).
Dental Simulator Market Share: The dental simulator market is expected to increase from US$ 368.8 million in 2023 to US$ 780.5 million in 2033. The dental simulator business is anticipated to capture a CAGR of 7.8% between 2023 and 2033.
Sleep Apnea Implants Market Growth: The sleep apnea implants market size is estimated to be valued at US$ 317.1 million in 2023 and is expected to reach US$ 1,158.1 million by 2033. The adoption of Sleep Apnea Implants is likely to advance at a CAGR of 13.8% during the forecast period.
Laser Therapy Devices Market Trends: The laser therapy devices market size is estimated to be valued at US$ 3 billion in 2023 and is expected to reach US$ 7 billion by 2033. The adoption of laser therapy devices is likely to advance at a CAGR of 8.8% during the forecast period.
DNA Polymerase Market Opportunity: The DNA polymerase market is likely to register positive growth with the overall valuation forecast to reach US$ 353.9 million in 2023. The demand for DNA Polymerases is projected to surge with a projected CAGR of 6.2% to reach US$ 647.5 million.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
For Sales Enquiries: firstname.lastname@example.org
LinkedIn | Twitter | Blogs
SOURCE: Future Market Insights, Inc.
View source version on accesswire.com: